Free Trial
LON:CRS

Crystal Amber (CRS) Share Price, News & Analysis

Crystal Amber logo
GBX 102 +1.00 (+0.99%)
As of 05:22 AM Eastern

About Crystal Amber Stock (LON:CRS)

Advanced

Key Stats

Today's Range
100
102
50-Day Range
99
112.64
52-Week Range
98
159
Volume
15,104 shs
Average Volume
91,219 shs
Market Capitalization
£60.73 million
P/E Ratio
N/A
Dividend Yield
76.92%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Crystal Amber and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRS Stock News Headlines

Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide. On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033.tc pixel
Crystal Amber Share Chat (CRS)
AMBER Alert Update: Missing Arkansas Teens Found
Crystal Amber Regulatory News
See More Headlines

CRS Stock Analysis - Frequently Asked Questions

Crystal Amber's stock was trading at GBX 119.22 on January 1st, 2026. Since then, CRS shares have decreased by 14.4% and is now trading at GBX 102.

Crystal Amber (LON:CRS) announced its quarterly earnings data on Tuesday, March, 31st. The company reported ($0.64) earnings per share for the quarter. The company had revenue of $0.34 million for the quarter. Crystal Amber had a negative trailing twelve-month return on equity of 1.18% and a negative net margin of 29.43%.

Shares of CRS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Crystal Amber investors own include Intel (INTC), B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC) and IQE (IQE).

Company Calendar

Last Earnings
3/31/2026
Today
5/14/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Asset Management
Sub-Industry
Steel Works
Current Symbol
LON:CRS
CIK
N/A
Fax
N/A
Employees
4,100
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (8.44)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£9.56 million
Net Margins
-29.43%
Pretax Margin
N/A
Return on Equity
-1.18%
Return on Assets
5.45%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
207.56
Quick Ratio
441.42

Sales & Book Value

Annual Sales
-£4.61 million
Price / Sales
-13.17
Cash Flow
GBX 152.01 per share
Price / Cash Flow
0.67
Book Value
GBX 152.33 per share
Price / Book
0.67

Miscellaneous

Outstanding Shares
59,535,000
Free Float
N/A
Market Cap
£60.73 million
Optionable
Not Optionable
Beta
0.21
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (LON:CRS) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners